Ashvin Dewan, MD
Sports Medicine · Sugar Land, TXNPI 1306089305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 75.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $449 and has fallen 81.4% since, to $83 in 2025. That places this record below the midpoint for sports medicine clinicians in TX, where the typical reported total is $1,700.
Across 35 payments — averaging $41.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Abbott$97
- Medinc Of Texas$89
- Zimmer Biomet$52
- Pacira Pharmaceuticals Incorporated$38
- Smith+Nephew$27
- plus $53 from 3 others
What the payments were for
- Food & beverage$1,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 24 | $1,111 |
| Abbott | 3 | $97 |
| Medinc Of Texas | 2 | $89 |
| Zimmer Biomet | 1 | $52 |
| Pacira Pharmaceuticals Incorporated | 1 | $38 |
| Smith+Nephew | 1 | $27 |
| Vertex | 1 | $21 |
| ERMI LLC | 1 | $19 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,469 in reported general payments places this provider in the 45th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 67 | $2,431 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 144 | $1,047 |
| Meloxicam | 154 | $504 |
| Methylprednisolone | 33 | $265 |
| Diclofenac Sodium | 21 | $257 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $228 |
| Methocarbamol | 47 | $215 |
| Gabapentin | 59 | $198 |
| Naproxen | 19 | $140 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $98 |
| Tramadol Hcl | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Sugar Land
- Kyle BorqueSugar Land$63K
- Laura LinscheidSugar Land$55K
- Bonnie GregorySugar Land$47K
- Ronak PatelSugar Land$39K
- Thomas DeberardinoSan Antonio$3.5M
- Robert ScheinbergDallas$2.2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- James GregoryHouston$565K
- John McDonaldAustin$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.